These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 15784871)
1. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Pluta RM; Dejam A; Grimes G; Gladwin MT; Oldfield EH JAMA; 2005 Mar; 293(12):1477-84. PubMed ID: 15784871 [TBL] [Abstract][Full Text] [Related]
2. Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates. Fathi AR; Pluta RM; Bakhtian KD; Qi M; Lonser RR J Neurosurg; 2011 Dec; 115(6):1213-20. PubMed ID: 21888479 [TBL] [Abstract][Full Text] [Related]
3. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090 [TBL] [Abstract][Full Text] [Related]
4. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672 [TBL] [Abstract][Full Text] [Related]
5. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. Pluta RM; Oldfield EH; Boock RJ J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984 [TBL] [Abstract][Full Text] [Related]
6. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. Pluta RM; Afshar JK; Boock RJ; Oldfield EH J Neurosurg; 1998 Mar; 88(3):557-61. PubMed ID: 9488312 [TBL] [Abstract][Full Text] [Related]
7. Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIa study. Oldfield EH; Loomba JJ; Monteith SJ; Crowley RW; Medel R; Gress DR; Kassell NF; Dumont AS; Sherman C J Neurosurg; 2013 Sep; 119(3):634-41. PubMed ID: 23706046 [TBL] [Abstract][Full Text] [Related]
8. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. Clatterbuck RE; Gailloud P; Ogata L; Gebremariam A; Dietsch GN; Murphy KJ; Tamargo RJ J Neurosurg; 2003 Aug; 99(2):376-82. PubMed ID: 12924713 [TBL] [Abstract][Full Text] [Related]
10. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Jung CS; Oldfield EH; Harvey-White J; Espey MG; Zimmermann M; Seifert V; Pluta RM J Neurosurg; 2007 Nov; 107(5):945-50. PubMed ID: 17977265 [TBL] [Abstract][Full Text] [Related]
11. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates. Clatterbuck RE; Gailloud P; Tierney T; Clatterbuck VM; Murphy KJ; Tamargo RJ J Neurosurg; 2005 Oct; 103(4):745-51. PubMed ID: 16266059 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y in the primate model of subarachnoid hemorrhage. Pluta RM; Deka-Starosta A; Zauner A; Morgan JK; Muraszko KM; Oldfield EH J Neurosurg; 1992 Sep; 77(3):417-23. PubMed ID: 1506889 [TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in a primate model of cerebral vasospasm. Iuliano BA; Pluta RM; Jung C; Oldfield EH J Neurosurg; 2004 Feb; 100(2):287-94. PubMed ID: 15086237 [TBL] [Abstract][Full Text] [Related]
14. The effect of timing of clot removal on chronic vasospasm in a primate model. Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894 [TBL] [Abstract][Full Text] [Related]
15. Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Macdonald RL; Zhang ZD; Curry D; Elas M; Aihara Y; Halpern H; Jahromi BS; Johns L Neurosurgery; 2002 Sep; 51(3):761-8; discussion 768-70. PubMed ID: 12188956 [TBL] [Abstract][Full Text] [Related]
16. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034 [TBL] [Abstract][Full Text] [Related]
17. Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage. Pradilla G; Thai QA; Legnani FG; Clatterbuck RE; Gailloud P; Murphy KP; Tamargo RJ Neurosurgery; 2005 Jul; 57(1 Suppl):184-90; discussion 184-90. PubMed ID: 15987587 [TBL] [Abstract][Full Text] [Related]
18. Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm. Aihara Y; Jahromi BS; Yassari R; Sayama T; Macdonald RL Neurosurgery; 2003 Mar; 52(3):661-7; discussion 666-7. PubMed ID: 12590692 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Woszczyk A; Deinsberger W; Böker DK Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885 [TBL] [Abstract][Full Text] [Related]
20. Report of selective cortical infarcts in the primate clot model of vasospasm after subarachnoid hemorrhage. Schatlo B; Dreier JP; Gläsker S; Fathi AR; Moncrief T; Oldfield EH; Vortmeyer AO; Pluta RM Neurosurgery; 2010 Sep; 67(3):721-8; discussion 728-9. PubMed ID: 20651629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]